HealthEquity, Inc.
92.66USD
-0.7000 (-0.75%)
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 861.7M | 999.6M | 1.2B | 1.3B | 1.4B | 1.5B |
| Q1 | 205.7M | 244.4M | 287.6M | 330.8M | 354.6M | — |
| Q2 | 206.1M | 243.5M | 299.9M | 325.8M | 350.7M | — |
| Q3 | 216.1M | 249.2M | 300.4M | 322.2M | 347.2M | — |
| Q4 | 233.8M | 262.4M | 311.8M* | 334.6M* | 364.0M | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | -.310 | .640 | 1.09 | 2.46 | 4.72 | 5.50 |
| Q1 | -.160 | .050 | .330 | .610 | .820 | — |
| Q2 | -.130 | .120 | .400 | .680 | .780 | — |
| Q3 | -.020 | .170 | .060 | .590 | 1.15 | — |
| Q4 | .000 |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| .300 |
| .297* |
| .569* |
| 1.10 |
| — |